Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho Min Kim

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Nucleic Acids Research|February 1, 2020
Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complexEunyoung Jeong, Seong-Gyu Lee, Hyun-Suk Kim, et al.
Cell|September 7, 2007
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist EritoranHo Min Kim, Beom Seok Park, Jung-In Kim, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[A Case of Sigmoid Rectal Cancer with a Vesicoconstrictor Fistula Curatively Resected after Neoadjuvant Chemotherapy]Manatsu Mizuno, Hideki Osawa, Ho Min Kim, et al.
Molecular Cancer Therapeutics|December 24, 2014
Novel glycosylated VEGF decoy receptor fusion protein, VEGF-Grab, efficiently suppresses tumor angiogenesis and progressionJung-Eun Lee, Chan Kim, Hannah Yang, et al.
Nature|May 7, 2013
Reconfiguration of the proteasome during chaperone-mediated assemblySoyeon Park, Xueming Li, Ho Min Kim, et al.
Experimental & Molecular Medicine|April 30, 2023
Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activationJimin Yang, Guo Nan Yin, Do-Kyun Kim, et al.
Nature Communications|April 4, 2023
Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanoporeKi-Baek Jeong, Minju Ryu, Jin-Sik Kim, et al.
Molecular and Clinical Oncology|July 23, 2016
First-line cetuximab-based chemotherapies for patients with advanced or metastatic <i>KRAS</i> wild-type colorectal cancerMamoru Uemura, Ho Min Kim, Tsuyoshi Hata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2024
[Analysis of Short-Term Results after Introduction of Robotic Gastrectomy for Gastric Cancer at Our Hospital]Junji Kawada, Minami Maruyama, Tomonori Nomura, et al.
International Journal of Clinical Oncology|July 29, 2016
Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nauseaHiroyoshi Takemoto, Junichi Nishimura, Takamichi Komori, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Nucleic Acids Research|February 1, 2020
Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complexEunyoung Jeong, Seong-Gyu Lee, Hyun-Suk Kim, et al.
Cell|September 7, 2007
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist EritoranHo Min Kim, Beom Seok Park, Jung-In Kim, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[A Case of Sigmoid Rectal Cancer with a Vesicoconstrictor Fistula Curatively Resected after Neoadjuvant Chemotherapy]Manatsu Mizuno, Hideki Osawa, Ho Min Kim, et al.
Molecular Cancer Therapeutics|December 24, 2014
Novel glycosylated VEGF decoy receptor fusion protein, VEGF-Grab, efficiently suppresses tumor angiogenesis and progressionJung-Eun Lee, Chan Kim, Hannah Yang, et al.
Nature|May 7, 2013
Reconfiguration of the proteasome during chaperone-mediated assemblySoyeon Park, Xueming Li, Ho Min Kim, et al.
Experimental & Molecular Medicine|April 30, 2023
Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activationJimin Yang, Guo Nan Yin, Do-Kyun Kim, et al.
Nature Communications|April 4, 2023
Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanoporeKi-Baek Jeong, Minju Ryu, Jin-Sik Kim, et al.
Molecular and Clinical Oncology|July 23, 2016
First-line cetuximab-based chemotherapies for patients with advanced or metastatic <i>KRAS</i> wild-type colorectal cancerMamoru Uemura, Ho Min Kim, Tsuyoshi Hata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2024
[Analysis of Short-Term Results after Introduction of Robotic Gastrectomy for Gastric Cancer at Our Hospital]Junji Kawada, Minami Maruyama, Tomonori Nomura, et al.
International Journal of Clinical Oncology|July 29, 2016
Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nauseaHiroyoshi Takemoto, Junichi Nishimura, Takamichi Komori, et al.
Pageof 14